Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DRDR.TO Stock Summary
In the News
DRDR.TO Financial details
Company Rating
-
Market Cap
49.43M
Income
-24.2M
Revenue
51.74M
Book val./share
0.14
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
340
Optionable
No
Shortable
Yes
Earnings
13 Nov 2023
P/E
-1.18
Forward P/E
-
PEG
-0.53
P/S
0.96
P/B
3.89
P/C
19
P/FCF
-6.47
Quick Ratio
0.31
Current Ratio
0.34
Debt / Equity
2.55
LT Debt / Equity
1.04
-
-
EPS (TTM)
-0.4
EPS next Y
-
EPS next Q
-
EPS this Y
27.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
172.41%
Revenue last 5Y
3.39%
Revenue Q/Q
-16.43%
EPS Q/Q
-
-
-
-
-
SMA20
55.32%
SMA50
143.33%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-177%
ROC
-1%
Gross Margin
31%
Oper. Margin
-38%
Profit Margin
-47%
Payout
-
Shs Outstand
89.87M
Shs Float
18M
-
-
-
-
Target Price
-
52W Range
0.085-1.05
52W High
-
52W Low
-
RSI
58.48
Rel Volume
5.29
Avg Volume
43.28K
Volume
229.01K
Perf Week
15.15%
Perf Month
90%
Perf Quarter
-
Perf Half Y
406.67%
-
-
-
-
Beta
-0.591678
-
-
Volatility
0.05%, 0.15%
Prev Close
2.7%
Price
0.76
Change
-1.3%
DRDR.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.55 | 0.56 | 0.47 | 1 | 1.06 | |
Net income per share | 0 | 0 | -0.01 | -0.33 | -0.42 | |
Operating cash flow per share | 0.04 | 0.04 | 0.05 | -0.15 | -0.17 | |
Free cash flow per share | 0.04 | 0.04 | 0.05 | -0.2 | -0.19 | |
Cash per share | 0.02 | 0.02 | 0.02 | 0.16 | 0.04 | |
Book value per share | 0.03 | 0.03 | 0 | 0.61 | 0.24 | |
Tangible book value per share | 0.02 | 0.02 | 0 | 0.18 | -0.16 | |
Share holders equity per share | 0.03 | 0.03 | 0 | 0.61 | 0.24 | |
Interest debt per share | 0.22 | 0.2 | 0.17 | 0.31 | 0.36 | |
Market cap | 370.64M | 370.64M | 370.64M | 60M | 30.05M | |
Enterprise value | 386.92M | 385.46M | 383.58M | 67.2M | 46.05M | |
P/E ratio | -1.62K | -3.08K | -360.19 | -3.83 | -1.42 | |
Price to sales ratio | 8.23 | 8.01 | 9.61 | 1.25 | 0.56 | |
POCF ratio | 101.23 | 115.35 | 87.79 | -8.45 | -3.6 | |
PFCF ratio | 106.84 | 119.9 | 92.94 | -6.34 | -3.16 | |
P/B Ratio | 163.89 | 173.1 | 3.25K | 2.03 | 2.55 | |
PTB ratio | 163.89 | 173.1 | 3.25K | 2.03 | 2.55 | |
EV to sales | 8.59 | 8.33 | 9.94 | 1.41 | 0.87 | |
Enterprise value over EBITDA | 110.53 | 105.88 | 181.19 | -5.54 | -3.05 | |
EV to operating cash flow | 105.68 | 119.96 | 90.85 | -9.47 | -5.52 | |
EV to free cash flow | 111.53 | 124.69 | 96.18 | -7.1 | -4.84 | |
Earnings yield | 0 | 0 | 0 | -0.26 | -0.7 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | -0.16 | -0.32 | |
Debt to equity | 7.61 | 7.45 | 121.34 | 0.49 | 1.48 | |
Debt to assets | 0.68 | 0.7 | 0.62 | 0.24 | 0.38 | |
Net debt to EBITDA | 4.65 | 4.07 | 6.11 | -0.59 | -1.06 | |
Current ratio | 0.54 | 0.59 | 0.54 | 1.14 | 0.44 | |
Interest coverage | 0.63 | 0.98 | -1.67 | -35.57 | -41.71 | |
Income quality | -15.12 | -26.65 | -4.11 | 0.46 | 0.4 | |
Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0 | |
Payout ratio | 0 | 0 | -1.95 | -0.03 | 0 | |
Sales general and administrative to revenue | 0.3 | 0.29 | 0.32 | 0.63 | 0.5 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.15 | |
Intangibles to total assets | 0.01 | 0.01 | 0.03 | 0.37 | 0.47 | |
Capex to operating cash flow | -0.05 | -0.04 | -0.06 | 0.33 | 0.14 | |
Capex to revenue | 0 | 0 | -0.01 | -0.05 | -0.02 | |
Capex to depreciation | -0.06 | -0.04 | -0.08 | -0.55 | -0.22 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.13 | 0.09 | |
Graham number | 0.04 | 0.03 | 0.02 | 2.12 | 1.49 | |
ROIC | 0.01 | 0.06 | -0.02 | -0.27 | -0.55 | |
Return on tangible assets | -0.01 | -0.01 | -0.05 | -0.41 | -0.87 | |
Graham Net | -0.23 | -0.21 | -0.22 | -0.36 | -0.52 | |
Working capital | -3.71M | -2.93M | -4.97M | 2.02M | -10.78M | |
Tangible asset value | 2.05M | 1.98M | -403K | 8.69M | -7.83M | |
Net current asset value | -18.42M | -16.24M | -16.34M | -13.17M | -23.53M | |
Invested capital | 7.61 | 7.45 | 121.34 | 0.49 | 1.48 | |
Average receivables | 0 | 2.86M | 3.13M | 4.98M | 5.98M | |
Average payables | 0 | 2.68M | 3.61M | 5.71M | 6.24M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 25.12 | 20.68 | 34.42 | 48.3 | 38.59 | |
Days payables outstanding | 34.07 | 30.25 | 66.09 | 75.3 | 56.99 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 14.53 | 17.65 | 10.61 | 7.56 | 9.46 | |
Payables turnover | 10.71 | 12.06 | 5.52 | 4.85 | 6.4 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.1 | -0.06 | -9.03 | -0.53 | -1.79 | |
Capex per share | 0 | 0 | 0 | -0.05 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.26 | 0.28 | 0.25 | 0 | 0.22 | |
Net income per share | -0.09 | -0.08 | -0.18 | 0 | -0.14 | |
Operating cash flow per share | -0.05 | -0.05 | -0.04 | 0 | -0.02 | |
Free cash flow per share | -0.06 | -0.06 | -0.05 | 0 | -0.02 | |
Cash per share | 0.08 | 0.03 | 0.04 | 0 | 0.04 | |
Book value per share | 0.5 | 0.43 | 0.27 | 0 | 0.14 | |
Tangible book value per share | 0.09 | 0.03 | -0.13 | 0 | -0.22 | |
Share holders equity per share | 0.5 | 0.43 | 0.27 | 0 | 0.14 | |
Interest debt per share | 0.3 | 0.31 | 0.36 | 0 | 0.37 | |
Market cap | 68.1M | 64.6M | 46.57M | 0 | 25.97M | |
Enterprise value | 79.74M | 79.01M | 63.2M | 16.01M | 43.26M | |
P/E ratio | -3.94 | -3.86 | -1.29 | 0 | -0.87 | |
Price to sales ratio | 5.23 | 4.68 | 3.7 | 0 | 2.25 | |
POCF ratio | -26.58 | -26.25 | -20.71 | 0 | -23.43 | |
PFCF ratio | -22.79 | -22.57 | -18.21 | 0 | -23.35 | |
P/B Ratio | 2.74 | 2.97 | 3.4 | 0 | 3.54 | |
PTB ratio | 2.74 | 2.97 | 3.4 | 0 | 3.54 | |
EV to sales | 6.12 | 5.72 | 5.02 | 1.16 | 3.75 | |
Enterprise value over EBITDA | -21.56 | -20.25 | -16.69 | -4.32 | -14.18 | |
EV to operating cash flow | -31.12 | -32.11 | -28.1 | -14.91 | -39.04 | |
EV to free cash flow | -26.69 | -27.61 | -24.72 | -14.46 | -38.9 | |
Earnings yield | -0.06 | -0.06 | -0.19 | 0 | -0.29 | |
Free cash flow yield | -0.04 | -0.04 | -0.05 | 0 | -0.04 | |
Debt to equity | 0.61 | 0.71 | 1.31 | 1.48 | 2.55 | |
Debt to assets | 0.26 | 0.29 | 0.38 | 0.38 | 0.46 | |
Net debt to EBITDA | -3.15 | -3.7 | -4.39 | -4.32 | -5.67 | |
Current ratio | 0.85 | 0.59 | 0.54 | 0.44 | 0.34 | |
Interest coverage | -42.05 | -37.59 | -43.28 | -45.12 | -11.85 | |
Income quality | 0.61 | 0.58 | 0.25 | 0.31 | 0.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.47 | 0.54 | 0.5 | 0.48 | |
Research and developement to revenue | 0.14 | 0.16 | 0.15 | 0.16 | 0.16 | |
Intangibles to total assets | 0.39 | 0.41 | 0.46 | 0.47 | 0.51 | |
Capex to operating cash flow | 0.17 | 0.16 | 0.14 | 0.03 | 0 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | 0 | 0 | |
Capex to depreciation | -0.35 | -0.32 | -0.22 | -0.02 | 0 | |
Stock based compensation to revenue | 0.09 | 0.08 | 0.08 | 0.12 | 0.06 | |
Graham number | 0.98 | 0.9 | 1.05 | 0 | 0.67 | |
ROIC | -0.08 | -0.08 | -0.19 | -0.12 | -0.12 | |
Return on tangible assets | -0.12 | -0.13 | -0.35 | -0.15 | -0.37 | |
Graham Net | -0.44 | -0.49 | -0.54 | 0 | -0.51 | |
Working capital | -2.1M | -5.94M | -6.2M | -10.78M | -13.62M | |
Tangible asset value | 4.32M | 1.27M | -6.55M | -7.83M | -11.6M | |
Net current asset value | -18.98M | -21.96M | -24.94M | -23.53M | -24.39M | |
Invested capital | 0.61 | 0.71 | 1.31 | 1.48 | 2.55 | |
Average receivables | 6.2M | 6.02M | 5.27M | 5.09M | 5.08M | |
Average payables | 7.68M | 8.37M | 7.53M | 6.31M | 7.34M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 41.91 | 38.93 | 32.6 | 36.7 | 35.39 | |
Days payables outstanding | 86.56 | 75.51 | 69.65 | 56.96 | 98.85 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.15 | 2.31 | 2.76 | 2.45 | 2.54 | |
Payables turnover | 1.04 | 1.19 | 1.29 | 1.58 | 0.91 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.17 | -0.19 | -0.66 | -0.3 | -1.01 | |
Capex per share | -0.01 | -0.01 | -0.01 | 0 | 0 |
DRDR.TO Frequently Asked Questions
What is MCI Onehealth Technologies Inc. stock symbol ?
MCI Onehealth Technologies Inc. is a CA stock , located in Toronto of On and trading under the symbol DRDR.TO
What is MCI Onehealth Technologies Inc. stock quote today ?
MCI Onehealth Technologies Inc. stock price is $0.76 today.
Is MCI Onehealth Technologies Inc. stock public?
Yes, MCI Onehealth Technologies Inc. is a publicly traded company.